BioPharma Credit PLC Financial Flexibility Index
BioPharma Credit PLC financial flexibility index. BioPharma Credit PLC (BPCR) has a Financial Flexibility Index of 4.50x as of June 2025. Free cash flow of $33.76 Million (operating CF $33.76 Million minus capex $0.00) represents 5% of total liabilities ($7.49 Million). See BioPharma Credit PLC (BPCR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BioPharma Credit PLC (2017–2024)
Financial flexibility index of BioPharma Credit PLC from 2017 to 2024. Historical Financial Flexibility Index trend for BioPharma Credit PLC across 8 annual periods. Check BioPharma Credit PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
BioPharma Credit PLC Financial Flexibility Index by Year (2017–2024)
BioPharma Credit PLC financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for BioPharma Credit PLC. For the full cash flow conversion analysis, see BPCR operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 6.24x | $111.91 Million | $111.91 Million | $17.94 Million | ▼ -19.6% |
| 2023 | 7.76x | $123.18 Million | $123.18 Million | $15.87 Million | ▲ +10.8% |
| 2022 | 7.01x | $184.28 Million | $184.28 Million | $26.30 Million | ▼ -49.9% |
| 2021 | 13.98x | $96.44 Million | $96.44 Million | $6.90 Million | ▲ +126.1% |
| 2020 | 6.18x | $58.07 Million | $58.07 Million | $9.39 Million | ▲ +18.6% |
| 2019 | 5.21x | $131.52 Million | $131.52 Million | $25.23 Million | ▲ +2.9% |
| 2018 | 5.07x | $67.14 Million | $67.14 Million | $13.25 Million | ▼ -36.0% |
| 2017 | 7.91x | $23.07 Million | $23.07 Million | $2.92 Million | — |